Iovate initiated a voluntary recall of 11 Hydroxycut products sold on the Canadian market as a result of FDA's assessment of 23 AD reports of liver related problems. On May 01, 2009, the Food and Drug Administration has issued an advisory urging consumers to discontinue the use of Hydroxycut products.
Depth of distribution
Distributed to retail level through wholesalers and distributors. Iovate does not export these products.